metoprolol has been researched along with Choroid Neovascularization in 1 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Choroidal hemangioma is a visual threatening condition for which treatments is neither uniform nor widely available." | 7.01 | Intravitreal metoprolol for circumscribed choroidal hemangiomas: a phase I clinical trial. ( Chaves, L; Correa, Z; Jorge, R; Messias, A, 2021) |
| "Choroidal hemangioma is a visual threatening condition for which treatments is neither uniform nor widely available." | 3.01 | Intravitreal metoprolol for circumscribed choroidal hemangiomas: a phase I clinical trial. ( Chaves, L; Correa, Z; Jorge, R; Messias, A, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaves, L | 1 |
| Messias, A | 1 |
| Correa, Z | 1 |
| Jorge, R | 1 |
1 trial available for metoprolol and Choroid Neovascularization
| Article | Year |
|---|---|
Intravitreal metoprolol for circumscribed choroidal hemangiomas: a phase I clinical trial.
Topics: Angiogenesis Inhibitors; Bevacizumab; Choroid Neoplasms; Choroidal Neovascularization; Fluorescein A | 2021 |